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A procedure is described for the rapid assessment of cataleptic activity (loss of righting, without head-drop and 
without eye closure) of phencyclidine-type drugs. Single- and cumulative-dosing procedures with phencyclidine and 
ketamine produced similar results. Pentobarbital produced loss of righting at doses which also induced head-drop and 
eye closure. Catalepsy was induced exclusively by the d-isomers of ketamine, 1-(1-phenylcyclohexyl)-3-methylpiperi- 
dine and a-dioxadrol. The procedure is suitable for studying compounds which may interact with phencyclidine 
receptors. 
Cumulative dosing procedure Phencyclidine Catalepsy Pigeons 
1. Introduction 
The cataleptic effect of PCP in pigeons (char- 
acterized by a loss of the righting reflex without 
"head-drop" ,  shown by an outstretched head and 
a ventrally flexed neck while the pigeon is laid on 
its back) is a simple test which may be pharmaco- 
logically specific in that various other CNS-de- 
pressant drugs appear to produce loss of righting, 
but only in combination with head-drop (Chen, 
1965). The test has been used in the characteriza- 
tion of benz(f)isoquinoline derivatives (Zimmer- 
man et al., 1983). The first aim of the present 
study was to investigate drug-induced catalepsy in 
pigeons using a procedure which allows the assess- 
ment of the entire dose-response curve during a 
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single experimental session (e.g. Wenger, 1980), 
and to compare these results to data obtained 
when a single drug dose is evaluated per session. 
Second, the pharmacological specificity of PCP-in- 
duced catalepsy was investigated further by com- 
paring in detail the cataleptic effects of PCP-like 
drugs with the effects of pentobarbital. Third, the 
stereospecificity of the catalepsy test in pigeons 
was explored by investigating several pairs of ster- 
eoisomers for their relative ability to induce cata- 
lepsy. 
2. Materials and methods 
2.1. Subjects 
The subjects were nine experimentally naive 
White Carneaux pigeons (weighing between 450- 
550 g) which were housed in individual cages with 
water, grit, mixed grain and Purina pigeon check- 
ers freely available. 
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2.2. Procedure 
The procedure was adapted from the procedure 
described by Chen (1965). A pigeon is held with 
the wings to the body and is laid on its back, while 
avoiding contact with its feet. Catalepsy was de- 
fined as the simultaneous occurrrence of 1) loss of 
the righting reflex, as evidenced by a failure of the 
pigeon to right itself within 15 s, 2) absence of 
head-drop (head-drop was defined as the head 
lying sideways and motionless on the observation 
surface during the entire 15 s test period, and 3) 
absence of eye closure. Handling of the pigeons 
and scoring were performed blind to the drug 
treatment. 
In the cumulative-dose procedure, injections 
were given i.m. (inj. vol. 1 ml/kg)  at 20 min 
intervals, and effects were tested 15 min after each 
injection. The dose of drug injected before each 
test was calculated to increase the total amount 
injected during the session by 1 / 4  log-unit steps. 
Cumulative dosing continued until a dose was 
reached at which all subjects showed catalepsy, or 
a limitation of further testing was imposed (e.g. 
solubility of drug). In the single dose procedure 
doses were administered per session which were 
equivalent to the total amounts injected in each of 
the several tests of the cumulative procedure. The 
time course of the drug effect was studied in both 
procedures by tests at 30, 60, 120, and 240 rain 
after the last injection of the session. Cumulative- 
dosing sessions were separated by at least 48 h 
intervals. Single-dose sessions were separated by 
24 h intervals. 
Five pigeons were submitted to both cumula- 
tive- and single-dosing tests of PCP and its con- 
gener ketamine, and four of these pigeons were 
submitted to comulative-dosing tests of the iso- 
mers of 1-(1-phenylcyclohexyl)-3-methylpiperidine 
(PCMP), ketamine and a-dioxadrol. Four pigeons 
were used to study the effects of pentobarbital in a 
cumulative-dosing procedure. 
2.3. Analysis 
For each drug and each subject the lowest dose 
which produced catalepsy (referred to as the 
threshold dose) and the longest time interval at 
which catalepsy was still present (referred to as the 
threshold time) were determined. The results of 
the cumulative- and single-dosing tests of PCP and 
ketamine were analyzed by means of two-factor 
ANOVA with repeated measures on both factors 
(drug, procedure) (Keppel, 1973), for log threshold 
dose and log threshold time data separately. Dif- 
ferences in mean log threshold dose and mean log 
threshold time between catalepsy-inducing drugs 
were analyzed by means of one-factor repeated 
measures ANOVA. 
2.4. Drugs 
The drugs used were phencyclidine (PCP), (+ ) -  
and ( - ) - ( P C M P )  hydrochlorides (K.C.R. and 
T.R.B., National Institutes of Health), (+)- ,  (+ ) -  
and ( - ) -ke tamine  hydrochlorides (Warner-Lam- 
ber t /Parke,  Davis and Co., Ann Arbor, MI), dex- 
oxadrol (( + )-a-dioxadrol) and levoxadrol ( ( - ) - a -  
dioxadrol) hydrochlorides (Upjohn Laboratories, 
Kalamazoo, MI; A.E.J. and P.N.H., National In- 
stitutes of Health), and pentobarbital sodium. PCP 
was dissolved in sterile water to which a small 
amount of lactic acid was added. All other drugs 
were dissolved in 0.9% NaCI. Doses of drugs are 
expressed in the forms described above. 
3. Results 
Dose-response and time-response curves of 
ketamine and PCP are shown in fig. 1. Analysis of 
the threshold dose data, obtained with ketamine 
and PCP, showed a significant drug effect (F(1,4) 
= 174.75, P < 0.001). Neither the main effect of 
procedure nor the interaction effect was significant 
(F(1, 4) = 1.47, F(1, 4) < 1.0, respectively). Overall 
mean threshold doses (+  1 S.E.M.) of ketamine 
and PCP were 1 4 +  1.8 mg/kg  and 1.5_+0.3 
m g /k g  respectively. Analysis of the threshold time 
data showed a significant drug effect (F(1, 4 )=  
16.0, P < 0.025). Other effects were not significant 
(F < 1.0). Overall mean threshold times were 33.4 
_ 4.1 min (ketamine) and 43.7 + 4.8 min (PCP). 
The results obtained with pentobarbital (fig. 1) 
indicate that there is no dose level at which all 
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Fig. 1. Dose-effect and time-effect curves of ketamine-induced 
(upper panel) and PCP-induced (middle panel) catalepsy (loss 
of righting without head-drop and without eye closure) in 
pigeons (n = 5). Ordinates: percentage of subjects showing 
catalepsy. Abscissae: dose administered (left panels) and time 
after the injection of the largest dose administered. The time-ef- 
fect curves were determined after all subjects had received the 
total dose specified in the figure. Lower panel: dose-effect and 
time-effect curves of pentobarbital in pigeons (n = 4). Ordinate: 
percentage of subjects showing loss of righting, head-drop, eye 
closure. Abscissae: cumulative dose administered, and time 
after the injection of the largest dose administered. 
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Fig. 2. Dose-effect and time-effect curves of catalepsy induced 
in pigeons (n = 4) by isomers of ketamine, PCMP and a-di- 
oxadrol. Ordinates: percentage of subjects showing catalepsy. 
Abscissae: cumulative dose administered and time after the 
injection of the largest dose administered. 
comitant  occurence of  head-drop and eye closure. 
Therefore, pentobarbi ta l  does not  produce cata- 
lepsy as defined herein. 
Catalepsy was induced exclusively by the ( + ) -  
isomers of ketamine, P C M P  and a-dioxadrol  (fig. 
2). Increasing doses of  levoxadrol were tested until 
the solubility limit was reached. Unlike the cata- 
lepsy induced by ketamine and PCP the highest 
dose of  ( - ) - P C M P  produced a loss of  righting in 
combinat ion  with wing flapping and vocalization. 
One pigeon died after the administrat ion of  this 
dose. The drugs which induced catalepsy differed 
significantly in potency (F(4, 12) = 17.05, P < 
0.001) and in durat ion of  action (F(4, 1 2 ) =  10.04, 
P < 0.001). The mean  threshold doses of PCP and 
of  ( + ) - P C M P  were significantly lower than the 
mean threshold doses of  the other drugs tested 
(P < 0.01, Newman-Keuls  procedure),  and the 
mean  threshold times of  ( + ) - P C M P  and dex- 
oxadrol  were significantly longer than the mean 
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threshold times of  the other drugs (P < 0.05). All 
other  differences were not  statistically significant. 
4. Discussion 
The cumulat ive-dosing procedure produced re- 
suits which are similar to results obtained in a 
single-dose procedure.  Therefore, the cumulative- 
dosing procedure appears to be useful for the 
rapid assessment of  drug-induced catalepsy in pi- 
geons. 
The finding that pentobarbi ta l  did not  produce 
catalepsy is in agreement with and extends results 
reported by Chen (1965) and constitutes further 
evidence of  the pharmacological  specificity of  the 
catalepsy test. 
Stereoselectivity is an impor tant  criterion for 
receptor-mediated actions of  drugs. Catalepsy was 
induced by the (+ ) - i somers  of  the drugs tested, 
but  not by the ( - ) - i som e r s .  These results confirm 
and extend previous observations on the stereo- 
selective PCP-like behavioral (e.g. Herling et al., 
1983) and biochemical (e.g. H a m p t o n  et al., 1982) 
effects of  these isomers. 
Phencyclidine can function as a discriminative 
stimulus in pigeons; a strong association between 
the potency of  agents to induce catalepsy and the 
potency to induce PCP-like discriminative effects 
in pigeons has been established (Leander et al., 
submitted).  
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